Close
|
Supplied by: Lotus Pharmaceutical Co., Ltd. |
|||||
|
SEQ_NO |
5 |
announcement date |
2022/03/16 |
Announcement time |
21:41:42 |
|
Topic |
Announcement of the Board of Directors' resolution for capital surpluses dividends |
||||
|
Date of events |
2022/03/16 |
What item it responds to |
paragraph 14 |
||
|
Declaration |
1.Date of the board of directors resolution : 2022/03/16 2.Year or quarter which dividends belong to: FY2021 3.Period which dividends belong to: 2021/01/01 ~ 2021/12/31 4.Appropriations of earnings in cash dividends to shareholders (NT$ per share): 0 5.Cash distributed from legal reserve and capital surplus to shareholders (NT$ per share): 1.93 6.Total amount of cash distributed to shareholders (NT$): 506,058,182 7.Appropriations of earnings in stock dividends to shareholders (NT$ per share): 0 8.Stock distributed from legal reserve and capital surplus to shareholders (NT$ per share): 0 9.Total amount of stock distributed to shareholders (shares): 0 10.Any other matters that need to be specified: None 11.Per value of common stock: NT$10 |
Warning
Lotus Pharmaceutical Co. Ltd. published this content on March 16, 2022 and is solely responsible for the information contained therein. Distributed by publicunedited and unmodified, on Mar 16, 2022 1:47:05 PM UTC.
Public now 2022
|
|
|
|
|
|
|
||||
|
||||
Trending Technical Analysis LOTUS PHARMACEUTICAL CO., LTD.
| Short term | Middle term | Long term | |
| Tendencies | Bullish | Bullish | Neutral |
Evolution of the income statement
|
To sell  To buy |
|
| Medium consensus | TO BUY |
| Number of analysts | 4 |
| Last closing price |
TWD99.70 |
| Average target price |
TWD143.50 |
| Average Spread / Target | 43.9% |
Comments are closed.